鑑定及びカウンセリングによりIP資産を評価する
弊所は、一特許に関する一鑑定から、複雑な特許ポートフォリオ又は訴訟に関する長期間にわたるカウンセリングまで、年間数百に上る鑑定を手掛けています。弊所は、日ごろから、特許の有効性、行使可能性、営業の自由(FTO)、特許権濫用、侵害回避問題、ライセンスの可能性、知的財産契約の構築や執行、及び輸出規制を手掛けています。弊所は、クライアント企業の法務、ビジネス、及び技術部門のスタッフと連携して、アイデアから収益を生み出すポートフォリオに関わる潜在的リスクや利益の特定に取り組んでいます。
特許取引のカウンセリングに加え、訴訟前戦略に関する助言も日常的に行っています。幅広い訴訟経験から弊所が得た見識をもって、相手方が提起しうる様々なタイプの議論に取り組みます。弊所の訴訟及びIP取引に関する経験を活かし、訴訟前や訴訟中にクライアント企業に有利な紛争和解へと導くことが可能です。
Filed an amicus brief on behalf of non-parties Toyota Motor Corporation, Honda Motor Company, Nissan Motor Company, DENSO Corporation, and Hyundai Motor Company in a Federal Circuit appeal involving issues related to standard-essential patents.
18-1363, -1380, -1382, -1732, Fed. Cir., Judges Newman, Chen, Hughes
Finnegan prepared and prosecuted patents for startup Hutchison Medipharma in the United States for the treatment of metastatic colorectal cancer. Those patents cover a small molecule, fruquintinib, which received approval in China.
Finnegan successfully generated patents to cover protease inhibitor Viracept®, for then startup company Agouron Pharmaceuticals, Inc. Agouron was ultimately acquired by Warner-Lambert (now part of Pfizer) based on the strength of the Viracept® patents, for $2.1 billion.
Webinar
January 11, 2024
Webinar
Seminar
September 5, 2023
Tel Aviv
IP Updates
Senate Legislation Proposes Changes to Patent Eligibility and PTAB Proceedings
June 27, 2023
Webinar
June 16, 2022
Webinar
Commentary
How I Made Partner: Finnegan's Danielle Duszczyszyn Shares Six Keys to Business Development Success
December 16, 2020
Charles T. Collins-Chase
Esther H. Lim Nominated as Candidate for President-Elect of the D.C. Bar
March 6, 2017
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.